170 related articles for article (PubMed ID: 16570075)
21. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
Kehl F; Cambj-Sapunar L; Maier KG; Miyata N; Kametani S; Okamoto H; Hudetz AG; Schulte ML; Zagorac D; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1556-65. PubMed ID: 11893593
[TBL] [Abstract][Full Text] [Related]
22. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats.
Kuczeriszka M; Badzyńska B; Kompanowska-Jezierska E
J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():179-85. PubMed ID: 17244949
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
[TBL] [Abstract][Full Text] [Related]
26. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor.
Sato M; Ishii T; Kobayashi-Matsunaga Y; Amada H; Taniguchi K; Miyata N; Kameo K
Bioorg Med Chem Lett; 2001 Dec; 11(23):2993-5. PubMed ID: 11714595
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.
Blanton A; Nsaif R; Hercule H; Oyekan A
J Hypertens; 2006 Sep; 24(9):1865-72. PubMed ID: 16915037
[TBL] [Abstract][Full Text] [Related]
29. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension.
Zhang Y; Wu JH; Vickers JJ; Ong SL; Temple SE; Mori TA; Croft KD; Whitworth JA
J Hypertens; 2009 Aug; 27(8):1609-16. PubMed ID: 19458537
[TBL] [Abstract][Full Text] [Related]
30. Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
Tanaka Y; Omura T; Fukasawa M; Horiuchi N; Miyata N; Minagawa T; Yoshida S; Nakaike S
Neurosci Res; 2007 Dec; 59(4):475-80. PubMed ID: 17933409
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures.
Renic M; Kumar SN; Gebremedhin D; Florence MA; Gerges NZ; Falck JR; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1285-93. PubMed ID: 22245774
[TBL] [Abstract][Full Text] [Related]
32. Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
Williams JM; Sarkis A; Lopez B; Ryan RP; Flasch AK; Roman RJ
Hypertension; 2007 Mar; 49(3):687-94. PubMed ID: 17210834
[TBL] [Abstract][Full Text] [Related]
33. 20-HETE synthesis inhibition attenuates traumatic brain injury-induced mitochondrial dysfunction and neuronal apoptosis via the SIRT1/PGC-1α pathway: A translational study.
Cui W; Wu X; Shi Y; Guo W; Luo J; Liu H; Zheng L; Du Y; Wang P; Wang Q; Feng D; Ge S; Qu Y
Cell Prolif; 2021 Feb; 54(2):e12964. PubMed ID: 33314534
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury.
Regner KR; Zuk A; Van Why SK; Shames BD; Ryan RP; Falck JR; Manthati VL; McMullen ME; Ledbetter SR; Roman RJ
Kidney Int; 2009 Mar; 75(5):511-7. PubMed ID: 19052533
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Fernandez MM; Gonzalez D; Williams JM; Roman RJ; Nowicki S
Eur J Pharmacol; 2012 Jul; 686(1-3):97-103. PubMed ID: 22575524
[TBL] [Abstract][Full Text] [Related]
36. 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.
Han X; Zhao X; Lan X; Li Q; Gao Y; Liu X; Wan J; Yang Z; Chen X; Zang W; Guo AM; Falck JR; Koehler RC; Wang J
J Cereb Blood Flow Metab; 2019 Aug; 39(8):1531-1543. PubMed ID: 29485354
[TBL] [Abstract][Full Text] [Related]
37. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
Hoff U; Lukitsch I; Chaykovska L; Ladwig M; Arnold C; Manthati VL; Fuller TF; Schneider W; Gollasch M; Muller DN; Flemming B; Seeliger E; Luft FC; Falck JR; Dragun D; Schunck WH
Kidney Int; 2011 Jan; 79(1):57-65. PubMed ID: 20962739
[TBL] [Abstract][Full Text] [Related]
39. Production of 20-HETE and its role in autoregulation of cerebral blood flow.
Gebremedhin D; Lange AR; Lowry TF; Taheri MR; Birks EK; Hudetz AG; Narayanan J; Falck JR; Okamoto H; Roman RJ; Nithipatikom K; Campbell WB; Harder DR
Circ Res; 2000 Jul; 87(1):60-5. PubMed ID: 10884373
[TBL] [Abstract][Full Text] [Related]
40. The role of 20-hydroxyeicosatetraenoic acid in cerebral arteriolar constriction and the inhibitory effect of propofol.
Hama-Tomioka K; Kinoshita H; Azma T; Nakahata K; Matsuda N; Hatakeyama N; Kikuchi H; Hatano Y
Anesth Analg; 2009 Dec; 109(6):1935-42. PubMed ID: 19923524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
